Gastrointestinal Cancer

Por Wasan, H
Publicado em 2006

The architecture of cancer.

Por Waxman, J., Wasan, H.
Publicado em 1992

Failure of normalisation of alpha fetoprotein concentration after successful treatment of teratoma.

Por Pandha, H. S., Wasan, H. S., Harrington, K., Waxman, J.
Publicado em 1995

Myeloma and benign intracranial hypertension.

Por Wasan, H., Mansi, J. L., Benjamin, S., Powles, R., Cunningham, D.
Publicado em 1992

Serum metalloproteinases and their inhibitors: markers for malignant potential.

Por Baker, T., Tickle, S., Wasan, H., Docherty, A., Isenberg, D., Waxman, J.
Publicado em 1994

Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document

Por Khan, S, Davidson, B, Goldin, R, Pereira, S, Rosenberg, W, Taylor-Robinson, S, Thillainayagam, A, Thomas, H, Thursz, M, Wasan, H
Publicado em 2002

High-intensity focused ultrasound: advances in technology and experimental trials support enhanced utility of focused ultrasound surgery in oncology

Por Malietzis, G, Monzon, L, Hand, J, Wasan, H, Leen, E, Abel, M, Muhammad, A, Price, P, Abel, P
Publicado em 2013

Ultrasound-guided trans-rectal high-intensity focused ultrasound (HIFU) for advanced cervical cancer ablation is feasible: a case report

Por Abel, M., Ahmed, H., Leen, E., Park, E., Chen, M., Wasan, H., Price, P., Monzon, L., Gedroyc, W., Abel, P.
Publicado no J Ther Ultrasound (2015)

Transrectal high-intensity focused ultrasonography is feasible as a new therapeutic option for advanced recurrent rectal cancer: report on the first case worldwide

Por Monzon, L, Wasan, H, Leen, E, Ahmed, H, Dawson, PM, Harvey, C, Muhamed, A, Hand, J, Price, P, Abel, PD
Publicado no Ann R Coll Surg Engl (2011)

CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone

Por Wasan, H S, Springett, G M, Chodkiewicz, C, Wong, R, Maurel, J, Barone, C, Rosbrook, B, Ricart, A D, Kim, S, Spano, J-P
Publicado em 2009

CDX2 mutations do not account for juvenile polyposis or Peutz–Jeghers syndrome and occur infrequently in sporadic colorectal cancers

Por Woodford-Richens, K L, Halford, S, Rowan, A, Bevan, S, Aaltonen, L A, Wasan, H, Bicknell, D, Bodmer, W F, Houlston, R S, Tomlinson, I P M
Publicado em 2001

SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway

Por Woodford-Richens, K. L., Rowan, A. J., Gorman, P., Halford, S., Bicknell, D. C., Wasan, H. S., Roylance, R. R., Bodmer, W. F., Tomlinson, I. P. M.
Publicado em 2001

Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial

Por Madi, A, Fisher, D, Wilson, R H, Adams, R A, Meade, A M, Kenny, S L, Nichols, L L, Seymour, M T, Wasan, H, Kaplan, R, Maughan, T S
Publicado em 2012

Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II stu...

Por Valle, J W, Wasan, H, Johnson, P, Jones, E, Dixon, L, Swindell, R, Baka, S, Maraveyas, A, Corrie, P, Falk, S, Gollins, S, Lofts, F, Evans, L, Meyer, T, Anthoney, A, Iveson, T, Highley, M, Osborne, R, Bridgewater, J
Publicado em 2009

Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patien...

Por Glynne-Jones, R., Hava, N., Goh, V., Bosompem, S., Bridgewater, J., Chau, I., Gaya, A., Wasan, H., Moran, B., Melcher, L., MacDonald, A., Osborne, M., Beare, S., Jitlal, M., Lopes, A., Hall, M., West, N., Quirke, P., Wong, Wai-Lup, Harrison, M.
Publicado no BMC Cancer (2015)